 |
| Photo Credit: CDC / Facebook |
The Centers for Disease Control and Prevention and Food and Drug Administration officials recommended to pause the Johnson & Johnson (Janssen) vaccine on Tuesday after six people developed a rare blood clot.
“Right now I’d like to stress these events appear to be extremely rare, however, COVID-19 vaccine safety is a top priority for the federal government and we take all reports of adverse events following vaccination very seriously,” said Acting FDA Commissioner Dr. Janet Woodcock.
As of April 12, more than 6.8 million doses were administered in the U.S., according to the joint CDC and FDA statement.
The six patients who developed the blood clot, cerebral venous sinus thrombosis (CVST), and thrombocytopenia, a low blood platelet count, were women ages 18-48. Heparin tends to be used to treat blood clots, but an alternative solution is necessary as it may be dangerous in this case.
In an interview with TODAY, Dr. Anthony Fauci reassured audiences that they should not be too concerned it as it is “a very, very rare event.”
Timothy W. Gordon, Ph.D., the State University of New York Buffalo State College’s vice president for student affairs, sent out a campus-wide email on Tuesday notifying students that they are postponing all campus vaccine appointments.
“While no severe adverse reactions have been reported among students who have received the J&J vaccine at our campus clinics, we encourage anyone who has received the J&J vaccine on campus or at a community vaccine site to monitor their health for possible severe adverse reactions,” he wrote.
Nicholas Gerwitz, a freshman at SUNY Buffalo State who received the Johnson & Johnson vaccine about two weeks ago, said that he wasn’t surprised because the vaccines are still new.
“I researched more into it before I freaked out. I was like out of the millions of people that have been vaccinated with it, only six have come forth with blood clots, so that just gave me a reassurance that I have a low chance statistically and that I shouldn’t be worried,” the television and film arts major said.
Gerwitz said that he’s opposed to vaccines being mandatory on college campuses.
“It’s kind of like contradicting between your personal choice to go to a college and your personal choice to get a vaccine that’s still extremely new,” the television and film arts major said.
On Wednesday, an advisory committee for the CDC decided that they need more time deciding whether to resume the administering of the Johnson & Johnson vaccine.
As of April 12, more than 6.8 million doses were administered in the U.S., according to the joint CDC and FDA statement.
The six patients who developed the blood clot, cerebral venous sinus thrombosis (CVST), and thrombocytopenia, a low blood platelet count, were women ages 18-48. Heparin tends to be used to treat blood clots, but an alternative solution is necessary as it may be dangerous in this case.
In an interview with TODAY, Dr. Anthony Fauci reassured audiences that they should not be too concerned it as it is “a very, very rare event.”
Timothy W. Gordon, Ph.D., the State University of New York Buffalo State College’s vice president for student affairs, sent out a campus-wide email on Tuesday notifying students that they are postponing all campus vaccine appointments.
“While no severe adverse reactions have been reported among students who have received the J&J vaccine at our campus clinics, we encourage anyone who has received the J&J vaccine on campus or at a community vaccine site to monitor their health for possible severe adverse reactions,” he wrote.
Nicholas Gerwitz, a freshman at SUNY Buffalo State who received the Johnson & Johnson vaccine about two weeks ago, said that he wasn’t surprised because the vaccines are still new.
“I researched more into it before I freaked out. I was like out of the millions of people that have been vaccinated with it, only six have come forth with blood clots, so that just gave me a reassurance that I have a low chance statistically and that I shouldn’t be worried,” the television and film arts major said.
Gerwitz said that he’s opposed to vaccines being mandatory on college campuses.
“It’s kind of like contradicting between your personal choice to go to a college and your personal choice to get a vaccine that’s still extremely new,” the television and film arts major said.
On Wednesday, an advisory committee for the CDC decided that they need more time deciding whether to resume the administering of the Johnson & Johnson vaccine.
Comments
Post a Comment